Prevalence and risk of migraine headaches in adult fragile X premutation carriers
about
Fragile X spectrum disordersFragile X-associated tremor/ataxia syndrome.Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related DisordersThe fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiologyTowards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation CarriersAssociated features in females with an FMR1 premutationModulation of the GABAergic pathway for the treatment of fragile X syndrome.Molecular Advances Leading to Treatment Implications for Fragile X Premutation CarriersCurrent research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome.Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two casesEndocrine Dysfunction in Female FMR1 Premutation Carriers: Characteristics and Association with Ill Health.Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.A family with two female siblings with compound heterozygous FMR1 premutation alleles.Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families.Fragile X-Associated Diminished Ovarian Reserve and Primary Ovarian Insufficiency from Molecular Mechanisms to Clinical Manifestations.Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals
P2860
Q26824376-64A2130E-324D-43B3-8916-BE6EE04E288CQ26852667-568CE8D3-CD2B-4705-87E8-C32DCEB3B67EQ28077980-CCE89915-5EC4-46A5-8B1B-430402D07256Q30249226-0B527587-8989-4C1E-A853-69727F29C131Q33863331-96AB0BA5-F489-4114-AF0E-CB4B9FE31FA0Q34000722-51012F19-DA03-4DBF-9231-102688302738Q34230612-E42AC171-8851-48A4-95AD-CEDB044040B8Q34575595-CD81B948-19D5-4DBA-A20F-63B4826C0311Q34983498-32371201-3BF1-49F2-9E2D-9BD7ED7894A5Q34983521-A740D80D-7754-49DD-A546-591468ECD071Q37449715-41694A3A-9C42-4A8E-9608-0BD8116CCB62Q37524454-F893F112-4CA4-484B-A6D2-CFE956C57F17Q37718076-49465F94-B898-4366-AA82-4F0C61750A9EQ39044125-A8DA7F50-82C0-4160-A383-7340B793D2E6Q40080863-EB806BA7-6D2D-428C-9093-3394CF1A1AE2Q41684295-CCD5F9AE-3DBF-4047-ACF2-76F9C7A0FFB2Q57300042-2C068B62-2D06-4320-AB68-960619CD2C09
P2860
Prevalence and risk of migraine headaches in adult fragile X premutation carriers
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence and risk of migraine headaches in adult fragile X premutation carriers
@en
Prevalence and risk of migraine headaches in adult fragile X premutation carriers.
@nl
type
label
Prevalence and risk of migraine headaches in adult fragile X premutation carriers
@en
Prevalence and risk of migraine headaches in adult fragile X premutation carriers.
@nl
prefLabel
Prevalence and risk of migraine headaches in adult fragile X premutation carriers
@en
Prevalence and risk of migraine headaches in adult fragile X premutation carriers.
@nl
P2093
P2860
P356
P1433
P1476
Prevalence and risk of migraine headaches in adult fragile X premutation carriers
@en
P2093
D V Nguyen
L Berkowitz-Sutherland
R Hagerman
P2860
P304
P356
10.1111/CGE.12109
P577
2013-02-21T00:00:00Z